The bacterial and viral specimen collection market facilitates the collection and transportation of specimens from patients for laboratory testing to detect infections. Specimen collection kits comprise swabs, viral transport media, blood collection kits, urine collection kits and others to collect samples from throat, nasal passages, blood, urine and other body sites. The sample collection process involves ensuring sample integrity during storage and transportation to laboratories.
The global bacterial and viral specimen collection market is estimated to be valued at US$ 29423.6 Mn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.
The growing prevalence of infectious diseases and increasing funding for clinical laboratory testing are majorly fueling the demand for specimen collection kits. Technological advancements in specimen collection and transportation solutions have made sample collection procedures convenient and reliable.
Key Takeaways
Key players operating in the bacterial and viral specimen collection market are Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd.
The rising incidences of infectious diseases coupled with increasing awareness regarding early diagnosis are contributing to the growing Bacterial And Viral Specimen Collection Market Forecasts products. Various initiatives taken by governments and private organizations to promote disease testing are also supporting market growth.
Major players are focused on expansion strategies and introducing novel specimen collection products to strengthen their global footprint. Partnerships with clinical laboratories and healthcare facilities help companies increase product access in different geographies.
Market Drivers
The increasing funding for infectious disease research is a major market driver. Government agencies globally are emphasizing on developing diagnostic tests, vaccines and therapeutics for high-impact infectious illnesses. Increased allocation of funds encourages market players to invest in advanced specimen collection product development. Growing awareness regarding benefits of early disease testing is accelerating the bacterial and viral specimen collection uptake.
Get more insights on Bacterial And Viral Specimen Collection Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian